hrp0094fc4.4 | Diabetes | ESPE2021
Park Julie
, Walsh Anna
, Kerr Sue
, Woodland Clare
, Southward Suzanne
, Deakin Mark
, Thursfield Rebecca
, Senniappan Senthil
,
Background: Cystic fibrosis related diabetes (CFRD) affects 40-50% of adults with Cystic Fibrosis (CF) and significantly decreases pulmonary function and affects life expectancy. Previous data highlighted that CFRD may be preventable or curable with the use of CFTR modulators, namely Ivakaftor. Kaftrio (Ivakaftor, tezacaftor and elexacaftor) has recently been licensed for use in CF. To our knowledge, its effect on glucose regulation in children and young peopl...